- Home
- CGO vs CTOR Comparison
CGO vs CTOR Comparison
Compare CGO & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGO
- CTOR
- Stock Information
- Founded
- CGO 2004
- CTOR 2021
- Country
- CGO United States
- CTOR United States
- Employees
- CGO N/A
- CTOR N/A
- Industry
- CGO Investment Managers
- CTOR
- Sector
- CGO Finance
- CTOR
- Exchange
- CGO Nasdaq
- CTOR NYSE
- Market Cap
- CGO 113.2M
- CTOR 89.9M
- IPO Year
- CGO N/A
- CTOR N/A
- Fundamental
- Price
- CGO $10.39
- CTOR $0.75
- Analyst Decision
- CGO
- CTOR Strong Buy
- Analyst Count
- CGO 0
- CTOR 2
- Target Price
- CGO N/A
- CTOR $4.50
- AVG Volume (30 Days)
- CGO 34.7K
- CTOR 50.5K
- Earning Date
- CGO 01-01-0001
- CTOR 02-14-2025
- Dividend Yield
- CGO 9.25%
- CTOR N/A
- EPS Growth
- CGO N/A
- CTOR N/A
- EPS
- CGO N/A
- CTOR N/A
- Revenue
- CGO N/A
- CTOR N/A
- Revenue This Year
- CGO N/A
- CTOR N/A
- Revenue Next Year
- CGO N/A
- CTOR N/A
- P/E Ratio
- CGO N/A
- CTOR N/A
- Revenue Growth
- CGO N/A
- CTOR N/A
- 52 Week Low
- CGO $7.90
- CTOR $0.69
- 52 Week High
- CGO $10.93
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- CGO 24.99
- CTOR N/A
- Support Level
- CGO $10.37
- CTOR N/A
- Resistance Level
- CGO $11.71
- CTOR N/A
- Average True Range (ATR)
- CGO 0.20
- CTOR 0.00
- MACD
- CGO -0.08
- CTOR 0.00
- Stochastic Oscillator
- CGO 9.52
- CTOR 0.00
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in global equities, convertible securities, and high-yield corporate bonds.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.